Clinical Trial Update: Pancreatic Tumor Cell Vaccine (GVAX), Cyclophosphamide, SBRT, and FOLFIRINOX in Patients With Resected Adenocarcinoma of the Pancreas [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating GVAX pancreatic tumor cell vaccine with cyclophosphamide, SBRT, and the FOLFIRINOX regimen in patients with resected pancreatic adenoca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma
• Pancreatic Cancer

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• FOLFIRINOX regimen (5-fluorouracil, leucovorin, oxaliplatin, irinotecan)
• GVAX pancreatic tumor cell vaccine (GVAX pancreatic tumor cell vaccine)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Pancreatic Cancer | Phase 2 | Status: COMPLETED | Results posted: 2024-08-14